About BCRX Dividend Returns
BioCryst Pharmaceuticals, Inc. (BCRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of BCRX over the past year?
BioCryst Pharmaceuticals, Inc. (BCRX) delivered a return of 1.63% over the past year. Since BCRX does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in BCRX be worth today?
A $10,000 investment in BioCryst Pharmaceuticals, Inc. one year ago would be worth $10,163 today, representing a gain of $163.
Q3Does BCRX pay dividends?
BioCryst Pharmaceuticals, Inc. (BCRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For BCRX, the total return equals the price-only return.
Q4Did BCRX beat the S&P 500?
No, BioCryst Pharmaceuticals, Inc. (BCRX) underperformed the S&P 500 by 13.83 percentage points over the past year. BCRX delivered a total return of 1.63%, compared to the S&P 500's 15.45%. This means a passive S&P 500 index fund outperformed BCRX by 13.83pp during this period.
Q5What is BCRX's worst drawdown?
BioCryst Pharmaceuticals, Inc. (BCRX) experienced a maximum drawdown of -44.24% over the past year, declining from its peak on 2025-06-03 to its trough on 2026-02-05. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is BCRX's long-term total return over 10, 20, or 30 years?
BioCryst Pharmaceuticals, Inc. (BCRX) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 339.7% (16.0% CAGR) — $10,000 would have grown to $43,970. Over 20 years: -56.0% total return (-4.0% CAGR) — $10,000 → $4,399. Over 30 years: -7.9% total return (-0.3% CAGR) — $10,000 → $9,210. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was BCRX's best and worst year?
BioCryst Pharmaceuticals, Inc.'s best calendar year was 2003 with a total return of 613.5%. Its worst year was 2008 with a total return of -77.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 690.8 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).